comparemela.com

Latest Breaking News On - Madrigal pharmaceuticals inc - Page 4 : comparemela.com

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states
Jamesm-daly
Rebecca-taub
Piper-sandler
Principal-financial-group-inc
Dana-investment-advisors-inc
Global-retirement-partners
Madrigal-pharmaceuticals-stock-performance
Securities-exchange-commission
Columbus-asset-advisors
Madrigal-pharmaceuticals
News-ratings-for-madrigal-pharmaceuticals-daily

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382.00 by Analysts at Citigroup

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $382.00 by Analysts at Citigroup
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Richards-levy
Rebecca-taub
Madrigal-pharmaceuticals-inc
Canaccord-genuity-group
Montaga-associates-inc
Analyst-recommendations-for-madrigal-pharmaceuticals
Citigroup
Madrigal-pharmaceuticals
News-ratings-for-madrigal-pharmaceuticals-daily
Global-retirement-partners

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $356.73 Average Price Target from Analysts

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to […]

United-states
America
Paula-friedman
Jamesm-daly
Madrigal-pharmaceuticals
Global-retirement-partners
Columbus-asset-advisors
Canaccord-genuity-group
Madrigal-pharmaceuticals-stock
Principal-financial-group-inc
Madrigal-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.